Omega Healthcare Investors, Inc. (NYSE:OHI – Get Free Report) has been given a consensus rating of “Hold” by the fifteen brokerages that are presently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and six have issued a buy rating on the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $49.2143.
A number of research analysts have recently weighed in on the company. Royal Bank Of Canada increased their price target on Omega Healthcare Investors from $47.00 to $48.00 and gave the company a “sector perform” rating in a research note on Monday, May 4th. BMO Capital Markets reaffirmed a “market perform” rating and set a $52.00 price objective on shares of Omega Healthcare Investors in a research note on Monday, May 4th. Wells Fargo & Company upped their price objective on Omega Healthcare Investors from $47.00 to $49.00 and gave the company an “equal weight” rating in a report on Monday, June 1st. Truist Financial cut their target price on Omega Healthcare Investors from $48.00 to $46.00 and set a “hold” rating on the stock in a research note on Tuesday, June 9th. Finally, Barclays began coverage on Omega Healthcare Investors in a report on Tuesday, July 7th. They set an “underweight” rating and a $51.00 target price on the stock.
Institutional Inflows and Outflows
Omega Healthcare Investors Stock Up 0.1%
Shares of OHI stock opened at $46.66 on Friday. The firm has a market cap of $14.14 billion, a price-to-earnings ratio of 16.66, a PEG ratio of 1.89 and a beta of 0.57. Omega Healthcare Investors has a 12 month low of $39.26 and a 12 month high of $52.39. The stock has a 50-day moving average price of $48.18 and a 200 day moving average price of $47.02.
Omega Healthcare Investors (NYSE:OHI – Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $1.19 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.68. Omega Healthcare Investors had a net margin of 66.96% and a return on equity of 15.76%. The business had revenue of $328.25 million during the quarter, compared to the consensus estimate of $266.97 million. During the same period in the previous year, the firm posted $0.77 earnings per share. Omega Healthcare Investors’s revenue for the quarter was up 16.2% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. Sell-side analysts predict that Omega Healthcare Investors will post 3.12 earnings per share for the current fiscal year.
Omega Healthcare Investors Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, August 14th. Investors of record on Monday, August 3rd were given a $0.68 dividend. The ex-dividend date was Monday, August 3rd. This represents a $2.72 dividend on an annualized basis and a dividend yield of 5.8%. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.67. Omega Healthcare Investors’s dividend payout ratio is 97.14%.
Omega Healthcare Investors Company Profile
Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.
Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.
Featured Articles
- Five stocks we like better than Omega Healthcare Investors
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
